|
No Metabolic Syndrome
|
Metabolic Syndrome
|
---|
Variable
|
Controls
|
HIV-1 untreated
|
HIV-1 cART
|
Controls
|
HIV-1 untreated
|
HIV-1 cART
|
---|
(n = 39)
|
(n = 32)
|
(n = 42)
|
(n = 10)
|
(n = 16)
|
(n = 12)
|
---|
Central systolic BP
|
113 ± 12
|
116 ± 10
|
114 ± 10
|
126 ± 7c
|
120 ± 13
|
110 ± 11b
|
Peripheral systolic BP
|
123 ± 13a
|
127 ± 11a
|
124 ± 11a
|
135 ± 7ac
|
129 ± 11a
|
120 ± 13a
|
Central diastolic BP
|
75 ± 7
|
78 ± 6
|
78 ± 8
|
81 ± 3c
|
78 ± 6
|
74 ± 7b
|
Peripheral diastolic BP
|
74 ± 7a
|
77 ± 6a
|
76 ± 8a
|
79 ± 3ac
|
72 ± 7a
|
72 ± 7ab
|
Central MAP
|
87 ± 8
|
91 ± 7
|
90 ± 9
|
96 ± 3c
|
92 ± 7
|
86 ± 8b
|
Peripheral MAP
|
90 ± 8a
|
93 ± 7a
|
92 ± 8a
|
98 ± 2ac
|
94 ± 7a
|
87 ± 8bc
|
Central PP
|
38 ± 9
|
38 ± 8
|
36 ± 7
|
45 ± 8c
|
41 ± 9
|
36 ± 8
|
Peripheral PP
|
49 ± 10a
|
50 ± 10a
|
47 ± 7a
|
56 ± 9a
|
52 ± 9a
|
45 ± 8ab
|
PP amplification (ratio)
|
1.33 ± 0.17
|
1.33 ± 0.14
|
1.32 ± 0.13
|
1.24 ± 0.12
|
1.29 ± 0.12
|
1.25 ± 0.19
|
Heart rate (beats/min)
|
67 ± 11
|
76 ± 10b
|
74 ± 11b
|
66 ± 7
|
74 ± 6
|
78 ± 13b
|
- Values (mmHg) are means ± SD. cART combined antiretroviral therapy, BP blood pressure, MAP mean arterial pressure, PP pulse pressure, aP < 0.001 for within-group central variable, bP < 0.01 versus within-group controls, cP < 0.001 vs. no metabolic syndrome controls